نتایج جستجو برای: azithromycin

تعداد نتایج: 4664  

2015
Christopher M. Parry Nga Tran Vu Thieu Christiane Dolecek Abhilasha Karkey Ruchi Gupta Paul Turner David Dance Rapeephan R. Maude Vinh Ha Chinh Nguyen Tran Phuong Le Thi Bay Pham Van Be La Tran Thi Phi Rang Nguyen Ngoc Aniruddha Ghose Sabina Dongol James I. Campbell Duy Pham Thanh Tuyen Ha Thanh Catrin E. Moore Soeng Sona Rajni Gaind Monorama Deb Ho Van Anh Sach Nguyen Van Hien Tran Tinh Nicholas P. J. Day Arjen Dondorp Guy Thwaites Mohamed Abul Faiz Rattanaphone Phetsouvanh Paul Newton Buddha Basnyat Jeremy J. Farrar Stephen Baker

Azithromycin is an effective treatment for uncomplicated infections with Salmonella enterica serovar Typhi and serovar Paratyphi A (enteric fever), but there are no clinically validated MIC and disk zone size interpretative guidelines. We studied individual patient data from three randomized controlled trials (RCTs) of antimicrobial treatment in enteric fever in Vietnam, with azithromycin used ...

Journal: :Journal of cellular physiology 2013
Siobhan C Gannon Melissa D Cantley David R Haynes Robert Hirsch P Mark Bartold

Azithromycin is an antibiotic with anti-inflammatory properties used as an adjunct to treat periodontitis, a common inflammatory mediated condition featuring pathologic alveolar bone resorption. This study aimed to determine the effect of azithromycin on human osteoclast formation and resorptive activity in vitro. Osteoclasts were generated from peripheral blood mononuclear cells stimulated wit...

2013
Carin Anagrius Britta Loré Jørgen Skov Jensen

OBJECTIVES To evaluate therapy for Mycoplasma genitalium infection with doxycycline or azithromycin 1 g compared to five days of azithromycin (total dose 1.5 g). METHODS A retrospective case study was performed among patients attending the STD-clinic in Falun, Sweden 1998-2005. All patients with a positive PCR test for M. genitalium were routinely offered a test of cure (toc). Response to dox...

2017
Elizabeth A. Lendermon Tiffany A. Coon Joseph S. Bednash Nathaniel M. Weathington John F. McDyer Rama K. Mallampalli

BACKGROUND Azithromycin, an antibiotic used for multiple infectious disorders, exhibits anti-inflammatory effects, but the molecular basis for this activity is not well characterized. Azithromycin inhibits IL-1β-mediated inflammation that is dependent, in part, on inflammasome activity. Here, we investigated the effects of azithromycin on the NACHT, LRR, and PYD domains-containing protein 3 (NA...

Journal: :The Journal of antimicrobial chemotherapy 2012
Raj S Padwal Mohamed Ben-Eltriki Xiaoming Wang Lee-Ann Langkaas Arya M Sharma Dan W Birch Shahzeer Karmali Dion R Brocks

OBJECTIVES Azithromycin is used widely for community-acquired infections. The timely administration of azithromycin in adequate doses minimizes treatment failure. Gastric bypass, a procedure that circumvents the upper gut, may compromise azithromycin plasma levels. We hypothesized that azithromycin concentrations would be reduced following gastric bypass. METHODS A single-dose pharmacokinetic...

2007
Mark Abelson Eugene Protzko Aron Shapiro Ana Garces-Soldana Lyle Bowman

OBJECTIVE The study was designed to evaluate the efficacy of an ophthalmic formulation of 1% azithromycin in DuraSite((R)) (AzaSite, InSite Vision, Alameda CA, USA) and demonstrate equivalence with 0.3% tobramycin ophthalmic solution, USP, for the treatment of bacterial conjunctivitis as defined by the resolution of clinical signs and the eradication of pathogens. DESIGN Prospective, randomiz...

2015
Paul A Corris Victoria A Ryan Therese Small James Lordan Andrew J Fisher Gerard Meachery Gail Johnson Chris Ward

BACKGROUND We conducted a placebo-controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. METHODS We compared azithromycin (250 mg alternate days, 12 weeks) with placebo. Primary outcome was FEV1 change at 12 weeks. RESULTS 48 patients were randomised; (25 azithromycin, 23 placebo). It was established, post randomisation that two did no...

Journal: :Antimicrobial agents and chemotherapy 2005
Yoshifumi Imamura Yasuhito Higashiyama Kazunori Tomono Koichi Izumikawa Katsunori Yanagihara Hideaki Ohno Yoshitsugu Miyazaki Yoichi Hirakata Yohei Mizuta Jun-Ichi Kadota Barbara H Iglewski Shigeru Kohno

The aim of the present study was to elucidate the effect of the macrolide antibiotic azithromycin on Pseudomonas aeruginosa. We studied the susceptibility to azithromycin in P. aeruginosa PAO1 using a killing assay. PAO1 cells at the exponential growth phase were resistant to azithromycin. In contrast, PAO1 cells at the stationary growth phase were sensitive to azithromycin. The divalent cation...

Journal: :The Journal of antimicrobial chemotherapy 1996
D Girard P A Regan W B Milisen J A Retsema A C Swindell

Azithromycin has been shown to preferentially distribute to infection loci. Due to the potential contribution of phagocytes as transporters of drug to these sites, there has been some concern that immunosuppression of the cellular arm of the host defence system would greatly reduce the delivery of azithromycin to sites of infection and hence impair efficacy. Therefore, we evaluated the pharmaco...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998
E C Oldfield W J Fessel M W Dunne G Dickinson M R Wallace W Byrne R Chung K F Wagner S F Paparello D B Craig G Melcher M Zajdowicz R F Williams J W Kelly M Zelasky L B Heifets J D Berman

We conducted a randomized, double-blind, placebo-controlled multicenter trial of azithromycin (1,200 mg once weekly) for the prevention of Mycobacterium avium complex (MAC) infection in patients with AIDS and a CD4 cell count of < 100/mm3. In an intent-to-treat analysis through the end of therapy plus 30 days, nine (10.6%) of 85 azithromycin recipients and 22 (24.7%) of 89 placebo recipients de...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید